BioSpace News Archive

Biotech Bay

“Monstrous” and “Crazy” CRISPR Research on Human Embryos Condemned Globally

Both the Chinese and American researchers involved in using CRISPR-Cas9 gene editing to alter the DNA of embryos for seven couples in China are under investigation. The work has also received near-universal condemnation worldwide.

November 27, 2018
·
5 min read
·
Mark Terry
Business

Abeona Therapeutics Fires CEO Over Allegations of Misconduct

Abeona did not specify the type of misconduct that Carsten Thiel engaged in, but it was serious enough to warrant termination.

November 27, 2018
·
2 min read
·
Alex Keown
Drug Development

Vertex’s Triple-Combo CF Drugs Dazzle in Preliminary Data from 2 Phase III Trials

Vertex Pharmaceuticals announced that two Phase III clinical trials of its triple combination of VX-659, tezacaftor and ivacaftor met their primary endpoint in cystic fibrosis (CF).

November 27, 2018
·
2 min read
·
Mark Terry
Oxford Immunotec to Participate in Two Investor Conferences This Week

Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, is scheduled to present at the following investor conferences this week.

November 27, 2018
·
1 min read
Policy

Annual Maudsley Health Conference held under the patronage of Ministry of Health and Prevention addresses Mental Health in the region

Abu Dhabi based Maudsley Health, which is directly affiliated with the prestigious Maudsley Hospital in the UK, held their annual mental health conference under the patronage of H.E. Dr Yousif Al Serkal and the Ministry of Health and Prevention at the Al Amal Psychiatric Hospital, Dubai.

November 27, 2018
·
2 min read
Concomitant use of sleeping pills and strong painkillers is common among people with Alzheimer’s disease

One in five people with Alzheimer’s disease (AD) who use a benzodiazepine are also concomitant users of an opioid, according to a new study from the University of Eastern Finland.

November 27, 2018
·
2 min read
Drug Development

Promore Pharma receives approval for Phase III study with PXL01 in India

Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, today announced that the Drug Controller General in India (DCGI) has approved the company’s application to start a clinical Phase III study with PXL01 to prevent post-surgical adhesions after tendon repair surgery.

November 27, 2018
·
4 min read
Microbix Wins Business Award of Excellence

Recognized with 2018 Business Innovation Award by MBOT

November 27, 2018
·
4 min read
Business

Oculis Strengthens its Global Clinical and Business Development Capabilities through Strategic Appointments to Senior Management Team

Oculis announces the appointments of Fabio Baschiera PharmD, MPh, Ph.D. as Vice President of Clinical Development, and Louie-Anne Gauthier M.Sc., as Vice President of Strategic Marketing, Business Development and Licensing.

November 27, 2018
·
3 min read
RIPE project receives additional $13 million to accelerate progress to redesign photosynthesis

Bill & Melinda Gates Foundation increases RIPE project investment to complement support from FFAR and DFID to improve yields for farmers worldwide

November 27, 2018
·
3 min read